top of page

We invite you to engage in an interactive roundtable with leading neurologists, researchers, and patients to help advance the discovery and implementation of ALS digital biomarkers in clinical trials through our collaborative efforts.

 

Joining our participatory roundtable, you will be the first to learn about our latest study results on ALS digital biomarkers as well as have the opportunity to hear why major pharmaceutical companies have joined the consortium to partner in our research, which will be expanded to include analyzing data from wearables and smartphones.

  

As always, we approach each roundtable to encourage out-of-the-box thinking, and to kick it off, we have an exciting agenda! Take a look below. 

This is an invite only event.

Speakers

Hosts & Speakers 

  • Twitter
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • Twitter
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • LinkedIn
icons8-link-60.png
Untitled (1226 x 322 mm) (4).png

Agenda

June 13th 2022 - 3:30PM EST, 12:30PM PST

5 minutes

5 minutes

10 minutes

20 minutes

5 minutes

10 minutes

3 minutes

15 minutes

15 minutes

2 minutes

Indu Navar, EverythingALS 

Welcome and opening remarks

Keynote: Kate Nycz

Diagnosed with ALS at 32

Elad Yom-Tov, Microsoft Research

Validating the ability to Detect ALS through Search Engine Interactions: BING

Amir Lahav, Mitsubishi Tanabe Pharma Holdings America

Patients Perspective on Digital Biomarkers

Q&A

Alan Taitz, EverythingALS

New Discoveries in EverythingALS Studies

Meera Gandhi, EverythingALS

New Study Kickoff - Multi-Modal, Remote and Supervised 

Sensors and Wearables

ZEPHYRx

Aural Analytics

FeetMe

Moderator: Wendy Ehler, Astra Zeneca

Open discussion and questions

Closing remarks and next steps  

Agenda

Participants

bottom of page